Authors’ Reply to Nicolas: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Pharmacokinetics"
DOI: 10.1007/s40262-019-00781-1
Abstract: We thank Dr. Nicolas for his detailed comments on our article [1]. These we refute from both general and particular perspectives. This response to Dr. Nicholas explains why we do not accept the premises of… read more here.
Keywords: bioequivalence; reply nicolas; ibe; article ... See more keywords